VOYA Q1 2026 Earnings Strong EPS Beat Amid Steady Performance National Advertising Review Board Recommends Niagen Modify or Discontinue Certain Tru Niagen NAD Dietary Supplement Claims Centuri CTRI Delivers Q1 2026 Beat EPS 002 vs 008 Expected Am Vanguard AVD Q3 2025 Earnings Miss by Significant Key Takeaways